Protocol ID

Official Title

Prinipcal Investigator

Lead CRC

Disease Site

Phase

CC-16047

ClinicalTrials.gov #

NCT02834052

 
(Poly-ICLC-IM) A Phase I/II Trial of Pembrolizumab and Poly ICLC in Patients with Metastatic Mismatch Repair-Proficient (MRP) Colon Cancer Dr. Asha Nayak-Kapoor     I/II

G1T28-207

ClinicalTrials.gov #

NCT04607668

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): (PRESERVE1) Dr. Asha Nayak-Kapoor     III